go to contents go to 1depth menu
Aiming to be a global drug maker

RESEARCH AREA

We will introduce about the various research areas of CJ HealthCare.

Extended-release
antithrombotic therapy
ATOMET SR Tab., CJ-30060,
30061, 30066, 30070
CJ-30065 CJ-30068 CJ-30071, 30072, 30073,
30074, 30075
Incrementally
Modified Drug
Change of
salt
Controlled
release
Fixed dose
combination
Dosage form
change
Change of
composition

CJ HealthCare Corp. is developing incrementally modified drugs based on fixed dose combinations, including the first generic product, and the drug delivery system (DDS).
It is commercializing products by mainly concentrating on pharmaceutical classes, such as the circulatory system and the endocrine system, based on research and pilot facilities with guaranteed quality. With its distinguished drug delivery system, CJ HealthCare Corp. will continue to develop products that can meet the unmet needs of the market.